Clinical trials update from the European Society of Cardiology Meeting 2009: AAA, RELY, PROTECT, ACTIVE-I, European CRT survey, German pre-SCD II registry, and MADIT-CRT

被引：36

作者：

Cleland, John G. F. ^{[1
]}

Coletta, Alison P. ^{[1
]}

Yassin, Ashraf ^{[1
]}

Buga, Laszlo ^{[1
]}

Torabi, Azam ^{[1
]}

Clark, Andrew L. ^{[1
]}

机构：

[1] Univ Hull, Dept Cardiol, Hull York Med Sch, Castle Hill Hosp, Kingston Upon Hull HU16 5JQ, Yorks, England

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2009年 / 11卷 / 12期

关键词：

Randomized controlled trials; Heart failure; CARDIAC-RESYNCHRONIZATION THERAPY; FIBRILLATION CLOPIDOGREL TRIAL; HEART-FAILURE; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; DEFIBRILLATOR; PREVENTION; DYSFUNCTION; IRBESARTAN; DESIGN;

D O I：

10.1093/eurjhf/hfp162

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This article provides information and a commentary on trials relevant to the pathophysiology, prevention, and treatment of heart failure presented at the annual meeting of the European Society of Cardiology held in Barcelona in 2009. The AAA study does not support the routine use of aspirin for the prevention of vascular events in patients with asymptomatic atherosclerosis. RELY suggests that dabigatran may be more effective than warfarin for the prevention of stroke in patients with atrial fibrillation. Rolofylline was not superior to placebo in improving outcomes in patients with acute heart failure enrolled in the PROTECT study, but dyspnoea was improved. Data from ACTIVE-I suggest that irbesartan does not provide additional therapeutic benefit in patients with atrial fibrillation who are well controlled on current therapy. The European cardiac resynchronization therapy (CRT) survey provides interesting epidemiological data on current CRT device usage. The German pre-SCD II registry identified a low prevalence of patients with a reduced ejection fraction following myocardial infarction. Implantation of CRT-D rather than an implantable cardioverter defibrillator in patients with mild heart failure and QRS >= 130 ms reduced the risk of hospitalization for heart failure in MADIT-CRT; mortality was similarly low with each device.

引用

页码：1214 / 1219

页数：6

共 24 条

[1] Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: A report from the CARE-HF study [J].

Cleland, J. G. F. ;

Freemantle, N. ;

Daubert, J-C ;

Toff, W. D. ;

Leisch, F. ;

Tavazzi, L. .

HEART, 2008, 94 (03) :278-283

[2] Clinical trials update from the American college of cardiology 2008: CARISMA, TRENDS, meta-analysis of Cox-2 studies, HAT, ON-TARGET, HYVET, ACCOMPLISH, MOMENTUM, PROTECT, HORIZON-HF and REVERSE [J].

Cleland, John G. F. ;

Coletta, Alison P. ;

Yassin, Ashraf ;

Hado, Hussien ;

Cullington, Damien ;

Abdellah, Ahmed Tageldien ;

Clark, Andrew L. .

EUROPEAN JOURNAL OF HEART FAILURE, 2008, 10 (06) :614-620

[3]

Cleland JGF, 2009, EUR J HEART FAIL, V11, P227, DOI [10.1093/eurjhf/hfp027, 10.1093/eurjhf/hfp071]

[4] Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902 [J].

Coletta, Alison P. ;

Tin, Lwin ;

Loh, P. Huan ;

Clark, Andrew L. ;

Cleland, John G. F. .

EUROPEAN JOURNAL OF HEART FAILURE, 2006, 8 (05) :547-549

[5]

Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1

[6] Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial [J].

Connolly, S. ;

Pogue, J. ;

Hart, R. ;

Pfeffer, M. ;

Hohnloser, S. ;

Chrolavicius, S. ;

Yusuf, S. .

LANCET, 2006, 367 (9526) :1903-1912

[7] Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events [J].

Connolly, S. ;

Yusuf, S. ;

Budaj, A. ;

Camm, J. ;

Chrolavicius, S. ;

Commerford, P. J. ;

Flather, M. ;

Fox, K. A. A. ;

Hart, R. ;

Hohnloser, S. ;

Joyner, C. ;

Pfeffer, M. ;

Anand, I. ;

Arthur, H. ;

Avezum, A. ;

Bethala-Sithya, M. ;

Blumenthal, M. ;

Ceremuzynski, L. ;

De Caterina, R. ;

Diaz, R. ;

Flaker, G. ;

Frangin, G. ;

Franzosi, M. -G. ;

Gaudin, C. ;

Golitsyn, S. ;

Goldhaber, S. ;

Granger, C. ;

Halon, D. ;

Hermosillo, A. ;

Hunt, D. ;

Jansky, P. ;

Karatzas, N. ;

Keltai, M. ;

Lanas, F. ;

Lau, C. P. ;

Le Heuzey, J. -Y. ;

Lewis, B. S. ;

Morais, J. ;

Morillo, C. ;

Oto, A. ;

Paolasso, E. ;

Peters, R. J. ;

Pfisterer, M. ;

Piegas, L. ;

Pipillis, T. ;

Proste, C. ;

Sitkei, E. ;

Swedberg, K. ;

Synhorst, D. ;

Talajic, M. .

AMERICAN HEART JOURNAL, 2006, 151 (06) :1187-1193

[8] Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation [J].

Connolly, S. J. ;

Yusuf, S. ;

Camm, J. ;

Chrolavicius, S. ;

Commerford, P. ;

Flather, M. ;

Hart, R. G. ;

Hohnloser, S. H. ;

Joyner, C. ;

Pfeffer, M. ;

Gaudin, C. ;

Blumenthal, M. ;

Marchese, C. ;

Pogue, J. ;

Hart, R. ;

Hohnloser, S. ;

Anand, I. ;

Arthur, H. ;

Avezum, A. ;

Budaj, A. ;

Ceremuzynski, L. ;

De Caterina, R. ;

Diaz, R. ;

Dorian, P. ;

Flaker, G. ;

Fox, K. A. A. ;

Franzosi, M. G. ;

Goldhaber, S. ;

Golitsyn, S. ;

Granger, C. ;

Halon, D. ;

Hermosillo, A. ;

Hunt, D. ;

Jansky, P. ;

Karatzas, N. ;

Keltai, M. ;

Kozan, O. ;

Lanas, F. ;

Lau, P. ;

Le Heuzey, J. Y. ;

Lewis, B. S. ;

Morais, J. ;

Morillo, C. ;

Paolasso, E. ;

Peters, R. J. ;

Pfisterer, M. ;

Piegas, L. ;

Pipilis, A. ;

Sitkei, E. ;

Swedberg, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (20) :2066-2078

[9] Dabigatran versus Warfarin in Patients with Atrial Fibrillation. [J].

Connolly, Stuart J. ;

Ezekowitz, Michael D. ;

Yusuf, Salim ;

Eikelboom, John ;

Oldgren, Jonas ;

Parekh, Amit ;

Pogue, Janice ;

Reilly, Paul A. ;

Themeles, Ellison ;

Varrone, Jeanne ;

Wang, Susan ;

Alings, Marco ;

Xavier, Denis ;

Zhu, Jun ;

Diaz, Rafael ;

Lewis, Basil S. ;

Darius, Harald ;

Diener, Hans-Christoph ;

Joyner, Campbell D. ;

Wallentin, Lars .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (12) :1139-1151

[10] The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment [J].

Cotter, Gad ;

Dittrich, Howard C. ;

Weatherley, Beth Davison ;

Bloomfield, Daniel M. ;

O'Connor, Christopher M. ;

Metra, Marco ;

Massie, Barry M. .

JOURNAL OF CARDIAC FAILURE, 2008, 14 (08) :631-640

← 1 2 3 →